StonvexLoading…
StonvexStonvexStonvexCore line items from AVX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $2.34M | $26.57K | $16.28K |
Operating Income | $-21.67M | $-10.10M | $-11.15M |
Net Income | $-33.20M | $-16.27M | $-11.73M |
EPS (Diluted) | $-2.15 | $-199.51 | $-1011.05 |
Total Assets | $194.96M | $10.76M | $17.37M |
Total Liabilities | $7.99M | $4.65M | $8.80M |
Cash & Equivalents | $22.14M | $489.87K | $3.88M |
Free Cash Flow OCF − CapEx | $-15.69M | $-6.11M | Not available |
Shares Outstanding | 92.94M | 172.25K | 58.41K |